# FDA recall D-1479-2016

> **Stason Pharmaceuticals, Inc.** · Class III · drug recall initiated 2016-08-23.

## Product

Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06

## Reason for recall

Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.

## Distribution

North Carolina

## Key facts

- **Recall number:** D-1479-2016
- **Recalling firm:** Stason Pharmaceuticals, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-08-23
- **Report date:** 2016-09-14
- **Termination date:** 2017-10-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Irvine, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1479-2016

## Citation

> AI Analytics. FDA recall D-1479-2016. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-1479-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*